-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Anixa Biosciences Inc quarterly/annual General and Administrative Expense history and growth rate from Q2 2019 to Q2 2024.
- Anixa Biosciences Inc General and Administrative Expense for the quarter ending July 31, 2024 was $1.67M, a 5.07% decline year-over-year.
- Anixa Biosciences Inc General and Administrative Expense for the twelve months ending July 31, 2024 was $7.18M, a 5.97% increase year-over-year.
- Anixa Biosciences Inc annual General and Administrative Expense for 2023 was $6.29M, a 12.3% decline from 2022.
- Anixa Biosciences Inc annual General and Administrative Expense for 2022 was $7.17M, a 1.4% increase from 2021.
- Anixa Biosciences Inc annual General and Administrative Expense for 2021 was $7.07M, a 26.4% increase from 2020.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)